Group for Innovative Cancer TreatmentDivision of Pathology
About the Division
Our team’s goal is to explore the cause of cancer, and to develop novel diagnostic and therapeutic methods for cancer patients. Therefore, team members are responsible for basic and translational researches of cancer biology and cancer treatment fields. To this end, we build hypothesis through both pathological samples and clinicopathological information. Since the in vitro and in vivo models mimicking human cancer tissue are required to solve molecular mechanisms, we develop novel in vitro models and examine whether our hypothesis are correct or not. We must further confirm our hypothesis by final validation studies using human samples.
Yuuki Ohara, Kota Amemiya, Hiroshi Nakamura
Student（Graduate School of Frontier Sciences, The university of Tokyo）
Shota Yamazaki, Yinghan Su
Erika Suzuki, Hojong Lee, Shoshi Hisamitsu, Daiki Maruyama, Asami Akutsu, Battugs Ochirdari
- To elucidate of the mechanism of cancer progression using ex vivo model mimicking tumor microenvironment
- Development of novel diagnostic and therapeutic methods focusing on tumor microenvironmental factors
- To elucidate purposeful transformation of cancer cells through histone adaptation and to put pathological perspective to practical use in the clinical field.
- Diagnostic device development and biomarker research through the morphological assessment of cancer physical property
Division of Pathology
Exploratory Oncology Research & Clinical Trial Center (EPOC)
National Cancer Center
E-mail：gishii●east.ncc.go.jp（● replace to ＠）